Participated · Seed · Jun 2026

Kimba develops a sleep system that creates a personalized sleep profile for each user and delivers precisely timed olfactory cues using proprietary water-based and plant-derived scent formulations. Its device continuously monitors biometric signals—breathing patterns, movement, heart rate variability and stress indicators—via built-in sensors and integrations with wearables such as WHOOP, Oura, Apple Watch, Fitbit and Garmin. An adaptive AI analyzes this data in real time to tailor scent delivery throughout the night with the goal of improving sleep depth, continuity and recovery without drugs or wakeful interruptions. The company sells pre-orders that include a six-month membership, the Kimba device and a six-month supply of personalized scents for $299. Kimba plans to deploy the new funding to support its commercial launch and accelerate its go-to-market efforts.

Participated · Series B · Jun 2026

California Naturals, founded in 2023 by Shelby Wild, is a natural-beauty brand. The company is pursuing retail expansion into national chains including Target, Ulta, and CVS and plans new category launches. Leadership is shifting as COO Hayden Hiatt—who previously held multiple leadership roles at Glossier—moves into the CEO role while founder Shelby Wild remains involved. Financially, the brand reported finishing the year 220% above its 2023 sales forecast and is projecting 800% year-over-year revenue growth. The company has raised more than $40 million across three funding rounds to date, including the recently closed Series B led by Align Ventures with participation from Elizabeth Street Ventures.

Participated · Equity · Oct 2025

Founded in 2023 by Stanford-trained, board-certified dermatologist Dr. James Kilgour, KilgourMD develops clinically grounded scalp treatment and prevention serums and recently launched a shampoo and conditioner. The brand centers on treating scalp aging as a root cause of hair thinning and offers a proprietary two-step scalp serum system whose trial showed 95% of participants had decreased shedding within six weeks and clinically meaningful regrowth by four months. KilgourMD reported profitability in 2025 and sells a bottle of scalp serum every 20 seconds, with more than one-third of customers recommending the products to others. Products are currently sold exclusively at kilgourmd.com. The company plans to expand its active ingredient pipeline, create new formulations, and run additional clinical trials focused on underserved populations.

Participated · Series B · May 2024

Found offers an integrated weight management program that combines clinician guidance, personal health coaching, community support and prescription interventions when needed. The startup emphasizes a holistic, personalized approach addressing sleep, mindful eating, movement, stress and biology while promoting body positivity. Since its 2020 launch, Found has helped members lose more than 300,000 pounds and reports average member weight loss of 10% by month six that is maintained thereafter. The service is available in 37 states (up from 31) at an average cost of about $100 per month and aims to reach nationwide availability by early 2022. Found says its annual run rate has grown 6x since the beginning of the year and it has assisted “tens of thousands” of members. The new capital will fund platform and infrastructure investment, user growth and hiring, and the company recently added a chief medical officer and a chief behavioral health officer to its leadership team.

Participated · Series B · Apr 2024

Headquartered in Palo Alto, Midi Health operates a nationwide virtual clinic that addresses gaps in women’s healthcare from perimenopause and menopause to broader chronic and preventive needs. The company’s proprietary AI engine analyzes patient charts to personalize diagnosis, streamline scheduling and documentation, and continuously refine clinical protocols using one of the industry’s largest women’s-health datasets. Midi currently has insurance contracts that give more than 45 million U.S. women in-network access to its services, and over 25,000 patients seek care on the platform each week. Outcomes data show a 28-percentage-point increase in breast-cancer screening adherence, an 11-point rise in colorectal screening adherence, and up to a 13 percent reduction in total cost of care, alongside clinically significant reductions in A1c and LDL levels. The business complements its clinical model with an expanding specialist roster covering OB-GYN, cardiology, endocrinology, mood disorders, dermatology, longevity, and more. Recent executive hires from Tesla, Google, Meta, Lyft, and Omada Health signal a push to scale operations and brand awareness. Following its latest financing, Midi is valued at more than $1 billion and plans to broaden its AI capabilities and extend comprehensive women’s care across every life stage.